LUNGevity Foundation and Thomas G. Labrecque Foundation Host 9th Annual "Run As One" Event

FOR IMMEDIATE RELEASE

Media Contact:
Victoria Shapiro
vshapiro@susandavis.com
(202) 414-0774

April 29 run/walk to raise funds for lung cancer research

WASHINGTON, DC (March 29, 2012)LUNGevity Foundation has teamed with the Thomas G. Labrecque Foundation to present the ninth annual “Run as One” event in New York City’s Central Park on Sunday, April 29, 2012.

LUNGevity is the nation’s largest lung cancer-focused nonprofit, and the Thomas G. Labrecque Foundation is a leading supporter of lung cancer research and awareness. The Foundations recently announced they are joining together to host a series of fundraising and lung cancer awareness events, kicking off with the 9th annual “Run As One” event. The two organizations will also sponsor Run As One teams for the 2012 Marine Corps Marathon and the 2012 ING New York City Marathon.

A qualifying event for the ING NYC Marathon, the 4-mile “Run as One” event is more than a cause race, attracting elite runners as well as recreational enthusiasts. “Run as One” also includes a 1.3-mile walk so families and participants of all ages can enjoy the event together. The race and walk will be followed by a festival at Rumsey Playground.

The popular race was launched by the Thomas G. Labrecque Foundation in 2003, and annually attracts as many as 10,000 runners and walkers as it calls attention to the fight against lung cancer.

To learn more and to register, go to www.lungevity.org/runasone.

WHAT:            “Run as One” Run and Walk Event

WHEN:            April 29, 2012

Registration/Bib Pick-Up Opens: 6:30 am
4-Mile Timed Run: 9:00 am
1.3 Mile Walk: 9:15 am
Post-Race Awards and Remarks: 10:15 am

COST:              4-Mile Timed Runner: $25
1.3 Mile Untimed Walker: $25

WHERE:           Central Park, New York, NY

For more information:  To learn more and to register, go to: www.lungevity.org/runasone

Questions pertaining to participating in the event or sponsorships should be directed to: runasone@lungevity.org

About LUNGevity Foundation

The mission of LUNGevity Foundation is to have a meaningful impact on improving lung cancer survival rates, ensure a higher quality of life for lung cancer patients, and provide a community for those impacted by lung cancer.

Through the support of critical research into the early detection and successful treatment of lung cancer, as well as providing information, resources and a community to patients and caregivers, LUNGevity is creating and sharing hope for cures, treatments and enhanced quality of life for lung cancer patients.  

LUNGevity seeks to inspire the nation to commit to ending lung cancer.

For more information, please visit www.lungevity.org.

About Thomas G. Labrecque Foundation

The Thomas G. Labrecque Foundation is committed to preventing lung cancer through education and research. At the age of 62, Tom Labrecque, the former Chairman of The Chase Manhattan Bank, a never-smoker, died from lung cancer eight weeks after being diagnosed. Tom’s family and friends started the Thomas G. Labrecque Foundation in 2002 to fight the #1 cancer killer in the United States. The Foundation has a two-pronged mission, to fund effective research and to educate people about lung cancer. In the process we want to break some of the stigmas associated with the disease, since many people believe it is a smokers’ disease. For more information about the Thomas G. Labrecque Foundation, please visit www.tglfoundation.com.

About Lung Cancer

  • 1 in 14 Americans is diagnosed with lung cancer in their lifetime
  • Lung cancer is the leading cause of cancer death, regardless of gender or ethnicity
  • Lung cancer kills almost twice as many women as breast cancer and more than three times as many men as About 55% of all new lung cancer diagnoses are among people who have never smoked or are former smokers
  • Only 16% of all people diagnosed with lung cancer will survive 5 years or more, BUT if it’s caught before it spreads, the chance for 5-year survival improves to 52%

CHICAGO (March 1, 2012) - LUNGevity Foundation, a non-profit committed to funding lung cancer research and advocacy, is participating in the craziness of March by launching the Make it a Slam Dunk – Stop Lung Cancer Now internet campaign.  Make it a Slam Dunk- Stop Lung Cancer Now is a month-long campaign dedicated to raising critical funds that will support the most promising lung cancer research.  The campaign kick-off is March 1 and runs the entire month.  LUNGevity hopes to engage basketball fans everywhere to come together and take part in the Make it a Slam Dunk – Stop Lung Cancer Now campaign. 

To tip it off, the following teams are organized and ready for the March 1 kickoff:

·         Team Spartans

·         Team Badgers

·         Team Bulldogs

·         Team Hokies

·         Team Cardinals

·         Team Tigers

Don’t see your favorite team?  Start your own.  One click to www.lungevity.org/slamdunk to begin.

The Make it a Slam Dunk – Stop Lung Cancer Now campaign gives everyone a chance to engage their competitive spirit during tournament time.  While contemplating bracket picks we hope to encourage individuals to be the big shot and join the team whose commitment is to the fight against lung cancer. 

Donations can be made to the Make it a Slam Dunk – Stop Lung Cancer Now campaign by visiting www.lungevity.org/slamdunk and donating to your favorite team or alma mater or to make a general gift.  All dollars raised will go to support LUNGevity’s commitment to lung cancer research in the areas of early detection and targeted therapies.

About LUNGevity Foundation

The mission of LUNGevity Foundation is to have a meaningful and immediate impact on improving lung cancer survival rates, ensure a higher quality of life for lung cancer patients, and provide a community for those impacted by lung cancer.

In order to accomplish our mission, LUNGevity funds the most promising research into the early detection and successful treatment of lung cancer. LUNGevity also supports the largest national grassroots lung cancer network, as well as the largest online support community for those affected by lung cancer. 

LUNGevity has the largest grants award program for lung cancer research among lung cancer nonprofit organizations in the United States.  In 2011 alone, it awarded $2 million to fund nine of the most promising lung cancer research proposals in the areas of early detection and targeted therapeutics.  Through the support of critical research, as well as providing information, resources and a community to patients and caregivers, LUNGevity is creating and sharing hope for cures, treatments and enhanced quality of life for lung cancer patients.  

The organization was recently awarded the coveted four-star charity ranking by Charity Navigator, American’s premier charity evaluator. The ranking recognizes LUNGevity’s sound fiscal management and commitment to accountability and transparency.

LUNGevity seeks to inspire the nation to commit to ending lung cancer. 

For more information, please visit www.lungevity.org.

About Lung Cancer 

  • Lung cancer is the leading cause of cancer death, regardless of gender or ethnicity.
  • Lung cancer impacts one in 14 Americans and kills more than breast, prostate, colorectal, leukemia, and melanoma cancers combined.
  • Lung cancer kills almost twice as many women as breast cancer, and more than twice as many men as prostate cancer.
  • About 55% of all new lung cancer diagnoses are among people who have never smoked or are former smokers.
Lung cancer accounts for 14% of all new cancer diagnoses but 27% of all cancer deaths.